CMP Pharma develops, manufactures and commercializes specialty pharmaceuticals, focused on niche oral liquid. injectable and topical products that solve unmet patient needs. CMP manufactures CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first and only FDA-approved oral suspension of the potassium-sparing diuretic spironolactone and the first FDA approved Potassium Phosphates Injection [15 mL Single-dose Glass Vial, 45 mM P (3 mM P/mL)] that will meet the critical demand for potassium phosphate while providing physicians and patients a safe alternative to using unapproved versions.
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth! Yes
ACC.23 Learning Pathways? (select all that apply) Pediatric and Congenital Heart Disease
First time Exhibitor? No